1. A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma. (28th February 2017) Authors: Benson, Al B.; Wainberg, Zev A.; Hecht, J. Randolph; Vyushkov, Dmitry; Dong, Hua; Bendell, Johanna; Kudrik, Fred Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma. (March 2017) Authors: Benson, Al B.; Wainberg, Zev A.; Hecht, J. Randolph; Vyushkov, Dmitry; Dong, Hua; Bendell, Johanna; Kudrik, Fred Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma. (28th February 2017) Authors: Hecht, J. Randolph; Benson, Al B.; Vyushkov, Dmitry; Yang, Yingsi; Bendell, Johanna; Verma, Udit Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma. (March 2017) Authors: Hecht, J. Randolph; Benson, Al B.; Vyushkov, Dmitry; Yang, Yingsi; Bendell, Johanna; Verma, Udit Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer. Issue 8 (September 2015) Authors: Hecht, J. Randolph; Douillard, Jean-Yves; Schwartzberg, Lee; Grothey, Axel; Kopetz, Scott; Rong, Alan; Oliner, Kelly S.; Sidhu, Roger Journal: Cancer treatment reviews Issue: Volume 41:Issue 8(2015) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer. Issue 8 (September 2015) Authors: Hecht, J. Randolph; Douillard, Jean-Yves; Schwartzberg, Lee; Grothey, Axel; Kopetz, Scott; Rong, Alan; Oliner, Kelly S.; Sidhu, Roger Journal: Cancer treatment reviews Issue: Volume 41:Issue 8(2015) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Familial Duodenal Somatostatinomatosis Not Associated With a Known Genetic Syndrome. Issue 8 (September 2022) Authors: Yu, Run; Rao, Jianyu; Zhai, Jing; Hecht, J. Randolph; Pisegna, Joseph R. Journal: Pancreas Issue: Volume 51:Issue 8(2022) Page Start: 1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of geography on prognostic outcomes of 21, 509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis. (June 2021) Authors: Yin, Jun; Dawood, Shaheenah; Cohen, Romain; Meyers, Jeff; Zalcberg, John; Yoshino, Takayuki; Seymour, Matthew; Maughan, Tim; Saltz, Leonard; Van Cutsem, Eric; Venook, Alan; Schmoll, Hans-Joachim; Goldberg, Richard; Hoff, Paulo; Hecht, J. Randolph; Hurwitz, Herbert; Punt, Cornelis; Diaz Rubio, Edu... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA). Issue 10 (1st April 2021) Authors: Hecht, J. Randolph; Lonardi, Sara; Bendell, Johanna; Sim, Hao-Wen; Macarulla, Teresa; Lopez, Charles D.; Van Cutsem, Eric; Muñoz Martin, Andres J.; Park, Joon Oh; Greil, Richard; Wang, Hong; Hozak, Rebecca R.; Gueorguieva, Ivelina; Lin, Yong; Rao, Sujata; Ryoo, Baek-Yeol Journal: Journal of clinical oncology Issue: Volume 39:Issue 10(2021) Page Start: 1108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗